Livanova PLC Stock News

LivaNova PLC (NASDAQ:LIVN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 1:05 PM EDT Company Participants Vladimir Makatsaria - CEO & Director Alex Shvartsburg - Chief Financial Officer Briana Gotlin - VP, IR Conference Call Participants Neha Begwani - Morgan Stanley Presentation Neha Begwani Managing Director Well thank you all for joining today. My name is Neha B...

LONDON--(BUSINESS WIRE)---- $LIVN #cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced the appointment of Donald (Don) Zurbay to the Company's Board of Directors, effective today. Zurbay will serve on the Audit and Compliance Committee for the Board. “LivaNova is pleased to welcome Don to our Board of Directors,” said William Kozy, Chair of the Bo...

LONDON--(BUSINESS WIRE)---- $LIVN #cardiacsurgery--LivaNova PLC announced it will host an Investor Day and product showcase on Wed., Nov. 12, 2025.

LONDON--(BUSINESS WIRE)---- $LIVN #cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Vladimir Makatsaria, Chief Executive Officer, and Alex Shvartsburg, Chief Financial Officer, will present a general business update during fireside chats at the two following September healthcare conferences in New York City: Baird 2025 Global Healthc...

LONDON--(BUSINESS WIRE)---- $LIVN #cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it initiated the commercial launch of the Essenz™ Perfusion System in China, the second-largest market for LivaNova heart-lung machines (HLMs) after the United States. The Essenz Perfusion System, which recently received regulatory approval from China's Na...

LivaNova PLC (NASDAQ:LIVN ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Ahmet Tezel - Chief Innovation Officer Alex Shvartsburg - Chief Financial Officer Briana Gotlin - Vice President of Investor Relations Stephanie Bolton - President of Global Epilepsy Vladimir A. Makatsaria - CEO & Director Conference Call Participants Adam Carl Maeder - Piper Sandler & Co...

LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC reported results for the second quarter ended June 30, 2025, and raised full-year 2025 guidance.

LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2025 results on Wed., Aug. 6, 2025, at 1 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its second-quarter 2025 results prior to the call. The audiocast will be accessible at www.livanova.com/eve...